Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Sbacchi

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Life Sciences|January 1, 1988
Antagonism by N-methyl levallorphan-methane sulphonate (SR 58002 C) of morphine-elicited acute and chronic central and peripheral effectsM Sbacchi, M Colombo, A La Regina, et al.
Brain Research|December 8, 1987
Dopamine denervation of the nucleus accumbens induces a selective increase in the number of delta-opioid binding sitesE Esposito, L Cervo, P Petrillo, et al.
Journal of Neuroscience Research|January 1, 1984
Double-blind evaluation of monosialoganglioside (GM1) therapy in strokeS Bassi, M G Albizzati, M Sbacchi, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 1, 1995
Central and peripheral analgesic agents: chemical strategies for limiting brain penetration in kappa-opioid agonists belonging to different chemical classesG Giardina, G D Clarke, M Grugni, et al.
The British Journal of Clinical Practice|July 1, 1986
Treatment of Parkinson's disease with orphenadrine alone and in combination with L-dopaS Bassi, M G Albizzati, E Calloni, et al.
Journal of Medicinal Chemistry|August 1, 1991
(1S)-1-(aminomethyl)-2-(arylacetyl)-1,2,3,4-tetrahydroisoquinoline and heterocycle-condensed tetrahydropyridine derivatives: members of a novel class of very potent kappa opioid analgesicsV Vecchietti, G D Clarke, R Colle, et al.
Drugs|January 1, 1987
Cyclandelate versus flunarizine. A double-blind study in a selected group of patients with dementiaM G Albizzati, S Bassi, E Calloni, et al.
Journal of Medicinal Chemistry|October 14, 1994
Selective kappa-opioid agonists: synthesis and structure-activity relationships of piperidines incorporating on oxo-containing acyl groupG Giardina, G D Clarke, G Dondio, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
Contribution of alpha-2 adrenoceptors to kappa opioid agonist-induced water diuresis in the ratY X Wang, G D Clarke, M Sbacchi, et al.
Chirality|January 1, 1992
Enantiospecificity of kappa receptors: comparison of racemic compounds and active enantiomers in two novel series of kappa agonist analgesicsR Colle, G D Clarke, G Dondio, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Life Sciences|January 1, 1988
Antagonism by N-methyl levallorphan-methane sulphonate (SR 58002 C) of morphine-elicited acute and chronic central and peripheral effectsM Sbacchi, M Colombo, A La Regina, et al.
Brain Research|December 8, 1987
Dopamine denervation of the nucleus accumbens induces a selective increase in the number of delta-opioid binding sitesE Esposito, L Cervo, P Petrillo, et al.
Journal of Neuroscience Research|January 1, 1984
Double-blind evaluation of monosialoganglioside (GM1) therapy in strokeS Bassi, M G Albizzati, M Sbacchi, et al.
Farmaco (Societa Chimica Italiana : 1989)|June 1, 1995
Central and peripheral analgesic agents: chemical strategies for limiting brain penetration in kappa-opioid agonists belonging to different chemical classesG Giardina, G D Clarke, M Grugni, et al.
The British Journal of Clinical Practice|July 1, 1986
Treatment of Parkinson's disease with orphenadrine alone and in combination with L-dopaS Bassi, M G Albizzati, E Calloni, et al.
Journal of Medicinal Chemistry|August 1, 1991
(1S)-1-(aminomethyl)-2-(arylacetyl)-1,2,3,4-tetrahydroisoquinoline and heterocycle-condensed tetrahydropyridine derivatives: members of a novel class of very potent kappa opioid analgesicsV Vecchietti, G D Clarke, R Colle, et al.
Drugs|January 1, 1987
Cyclandelate versus flunarizine. A double-blind study in a selected group of patients with dementiaM G Albizzati, S Bassi, E Calloni, et al.
Journal of Medicinal Chemistry|October 14, 1994
Selective kappa-opioid agonists: synthesis and structure-activity relationships of piperidines incorporating on oxo-containing acyl groupG Giardina, G D Clarke, G Dondio, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1994
Contribution of alpha-2 adrenoceptors to kappa opioid agonist-induced water diuresis in the ratY X Wang, G D Clarke, M Sbacchi, et al.
Chirality|January 1, 1992
Enantiospecificity of kappa receptors: comparison of racemic compounds and active enantiomers in two novel series of kappa agonist analgesicsR Colle, G D Clarke, G Dondio, et al.
Pageof 3